NVUS

Novus Therapeutics Stock Price

0.95
-0.0303 (-3.09%)
0.95
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Novus Therapeutics Inc NVUS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0303 -3.09% 0.95 16:00:04
Close Price Low Price High Price Open Price Previous Close
0.9538 0.94 1.02 1.02 0.9803
Bid Price Ask Price Spread News
0.95 0.999 0.049 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
878 308,919 $ 0.9749553 $ 301,182 7,287,970 0.25 - 1.45
Last Trade Time Type Quantity Stock Price Currency
16:00:00 392 $ 0.95 USD

Novus Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 22.08M 23.24M 19.79M $ - $ - -1.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Novus Therapeutics News

Date Time Source News Article
9/24/202019:45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
9/24/202019:45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
9/15/202017:19Edgar (US Regulatory)Current Report Filing (8-k)
9/15/202016:56Business WireNovus Therapeutics to Present at H.C. Wainwright and Cantor..
9/14/202016:31Business WireNovus Therapeutics Announces Acquisition of Anelixis..
9/04/202016:26Edgar (US Regulatory)Current Report Filing (8-k)
8/18/202016:36Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NVUS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.99021.050.87130.9640595731,306-0.0402-4.06%
1 Month0.40541.350.3421011.1119,403,9090.5446134.34%
3 Months0.4651.350.3421011.086,793,0700.485104.3%
6 Months0.39961.450.30011.023,625,5170.5504137.74%
1 Year0.65961.450.251.001,934,0350.290444.03%
3 Years5.428.610.251.15706,112-4.47-82.47%
5 Years10.4112.930.251.39581,719-9.46-90.87%

Novus Therapeutics Description

Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: Foam Platform(OP0201 and OP0202) and Surfactant Program(OP0201). OP0102 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP0201 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction.
Your Recent History
NASDAQ
NVUS
Novus Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200930 20:15:22